Intrinsic Imaging Awarded Another Pivotal Multiple-Reader Multiple-Case (MRMC) Study to Assess the Clinical Performance of CAD Software

Bolton, MA, San Antonio, TX, May 17, 2017 — Intrinsic Imaging, a full-service medical imaging core lab providing comprehensive services in support of Phase I-IV clinical trials and Class I, II, III medical device trials, announces today the award of another multiple-reader multiple-case (MRMC) study to assess the clinical performance of computer aided detection (CAD) software.

Throughout this trial, Intrinsic Imaging will provide comprehensive core lab services and manage all aspects of the clinical trial. These services include providing medical guidance and all case reviewers who will perform over 14400 reviews without CAD and with CAD to evaluate the software's clinical performance.

Intrinsic Imaging's MRMC CAD Team was selected for this trial due to its operational success in successfully completing many MRMC CAD studies that have resulted in multiple FDA clearances of computer aided detection software.

"Intrinsic Imaging is the industry leader in conducting large multi-reader multi-case CAD trials," said Todd Joron, President and COO at Intrinsic Imaging. "Whether it be conventional CAD, artificial intelligence (AI) or other machine learning software, Intrinsic Imaging's success in managing MRMC studies brings unmatched value to clients looking to assess the clinical performance of their computer assisted software."

This trial will be conducted within Intrinsic Imaging's quality framework. With its portfolio of five ISO certifications, Intrinsic Imaging has the most comprehensive and sophisticated quality management system in the industry.